ExodusPoint Capital Management’s Exact Sciences EXAS Stock Holding History

ExodusPoint Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.15M	Buy	39,600 +5,700	+17%	+$587K	0.03%	499
2025 Q4	$3.44M	Buy	+33,900	New	+$2.72M	0.03%	599

Other funds holding EXAS

VanEck Associates

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

ExodusPoint Capital Management's EXAS Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 266,329 shares — an estimated $27.4M sold.

ExodusPoint Capital Management first reported a position in EXAS in Q1 2019 and held it in 19 quarters. The position peaked at $27M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

ExodusPoint Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 266,329 Exact Sciences shares in Q1 2026, an estimated $27.4M.
ExodusPoint Capital Management first reported a position in Exact Sciences in Q1 2019 and held it in 19 quarters.
ExodusPoint Capital Management's Exact Sciences position peaked at $27M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.